June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Reversal of aging-induced and glaucoma-induced vision loss by in vivo epigenetic reprogramming
Author Affiliations & Notes
  • Bruce Ksander
    Mass Eye & Ear / Schepens, Harvard Medical School, Boston, Massachusetts, United States
  • Yuancheng Lu
    Paul F. Glenn Center for Aging Research at Harvard, Boston, Massachusetts, United States
    Blavatnik Institute, Dept of Genetics, Harvard, Boston, Massachusetts, United States
  • Anitha Krishnan
    Mass Eye & Ear / Schepens, Harvard Medical School, Boston, Massachusetts, United States
  • Benedikt Brommer
    Boston Childrens Hospital, Department of Neurology, Harvard, Boston, Massachusetts, United States
  • Xiao Tian
    Paul F. Glenn Center for Aging Research at Harvard, Boston, Massachusetts, United States
    Blavatnik Institute, Dept of Genetics, Harvard, Boston, Massachusetts, United States
  • Margarita Meer
    Division of Genetics, Department of Neurology, Bigham and Womens Hospital, Harvard, Boston, Massachusetts, United States
  • Daniel Vera
    Paul F. Glenn Center for Aging Research at Harvard, Boston, Massachusetts, United States
    Blavatnik Institute, Dept of Genetics, Harvard, Boston, Massachusetts, United States
  • Chen Wang
    Boston Childrens Hospital, Department of Neurology, Harvard, Boston, Massachusetts, United States
  • Qiurui Zeng
    Paul F. Glenn Center for Aging Research at Harvard, Boston, Massachusetts, United States
    Blavatnik Institute, Dept of Genetics, Harvard, Boston, Massachusetts, United States
  • Doudou Yu
    Paul F. Glenn Center for Aging Research at Harvard, Boston, Massachusetts, United States
    Blavatnik Institute, Dept of Genetics, Harvard, Boston, Massachusetts, United States
  • Steve Horvath
    Human Genetics, David Geffen School of Medicine, Los Angeles, California, United States
  • Meredith S Gregory-Ksander
    Mass Eye & Ear / Schepens, Harvard Medical School, Boston, Massachusetts, United States
  • Zhigang He
    Boston Childrens Hospital, Department of Neurology, Harvard, Boston, Massachusetts, United States
  • David Sinclair
    Paul F. Glenn Center for Aging Research at Harvard, Boston, Massachusetts, United States
    Blavatnik Institute, Dept of Genetics, Harvard, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Bruce Ksander, Iduna (C); Yuancheng Lu, Iduna (I), Iduna (P); Anitha Krishnan, None; Benedikt Brommer, None; Xiao Tian, None; Margarita Meer, None; Daniel Vera, None; Chen Wang, None; Qiurui Zeng, None; Doudou Yu, None; Steve Horvath, None; Meredith Gregory-Ksander, None; Zhigang He, None; David Sinclair, Iduna (P), Iduna (I)
  • Footnotes
    Support  The work was supported by the Harvard Medical School Epigenetics Seed Grant Program and Development Grant Program, The Paul F. Glenn Foundation for Medical Research, a kind gift from Edward Schulak, and NIH awards R01AG019719 (to D.A.S), R01EY026939 and R01EY021526 (to Z.H.), and R01GM065204 (to V.N.G.). We thank Boston Children's Hospital Viral Core, which is supported by NIH5P30EY012196, and Schepen Eye Institute Core facilities, supported by NEI-P30EY003790. X.T. was supported by NASA Postdoctoral Fellowship 80NSSC19K0439; D.V. by NIH training grant T32AG023480; J.-H.Y.was partially supported by National Research Foundation of Korea (2012R1A6A3A03040476); B.R.K. partially by the St Vincent de Paul Foundation; and M.G.K. by NEI award R21EY030276.
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 2364. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bruce Ksander, Yuancheng Lu, Anitha Krishnan, Benedikt Brommer, Xiao Tian, Margarita Meer, Daniel Vera, Chen Wang, Qiurui Zeng, Doudou Yu, Steve Horvath, Meredith S Gregory-Ksander, Zhigang He, David Sinclair; Reversal of aging-induced and glaucoma-induced vision loss by in vivo epigenetic reprogramming. Invest. Ophthalmol. Vis. Sci. 2020;61(7):2364.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : DNA methylation (Horvath epigenetic clock) is a biomarker of aging, but whether accumulating epigenetic signals simply denote age or regulate aging is unclear. In vitro reprogramming using the four Yamanaka genes (OSKM) removes epigenetic signals and dedifferentiates mature cells into iPS cells. However, in vivo OSKM reprogramming produces teratomas. We hypothesize that transient reprogramming in vivo, using only three Yamanaka genes (OSK) will partially reprogram cells and remove epigenetic signals, reversing age and restoring youthful cellular function without dedifferentiation or tumor formation.

Methods : Intravitreal injection of Dox-inducible AAV2-OSK (Oct4, Sox2, Klf4) resulted in retinal ganglion cell (RGCs) specific OSK expression. In the microbead-induced mouse glaucoma model, optomotor reflex (OMR) and pattern ERG (pERG) were measured at 3 wks, followed by intravitreal AAV2-OSK. At 4 wks post OSK treatment, OMR, pERG, and axon counts were performed. Negative controls: AAV-OSK-off, vehicle only, and no treatment. In aging, baseline OMR and pERG were measured in 4 and 12-month-old mice followed by intravitreal AAV2-OSK. 4 wks post OSK treatment, OMR and pERG were repeated. Specific sh-RNA knocked-down Tet 1,2 demethyl transferases. FACS sorted RGCs were used for RNA-seq and epigenetic clock analysis.

Results : Microbead injection induced elevated IOP for 4 wks, causing significantly reduced OMR, pERG, and axon counts in control groups. Transient OSK treatment, initiated after glaucoma-induced injury had occurred, significantly increased axon density (50.85±2.2 vs 42.21±1.2 axons 104/mm2) and restored OMR (0.28±.01 vs 0.22±.01 cyc/deg) and pERG (7.04±.56 vs 4.07±.20 Amp μV) OSK-on vs OSK-off. In aged mice, transient OSK treatment increased OMR (0.32±.02 vs 0.22±.02 cyc/deg) and pERG (5.0±.5 vs 2.6±.2 Amp μV) that was blocked by knock-down of Tet 1,2 indicating a dependence on epigenetic reprogramming. RNA-seq analysis of purified RGCs from OSK treated and control mice (young vs old) indicated reprogrammed genes were predominantly in the sensory pathway. OSK treatment significantly reduced RGC age as measured by the epigenetic clock.

Conclusions : These data indicate DNA methylation is not just a correlate of age, but a regulator of aging. Old cells retain a “youthful” record of epigenetic information that can be accessed by partial reprogramming to restore tissue function and reverse aging.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×